Wolfe, Andrew L.

RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer

Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature

RNA and protein synthesis mechanismsDNA and Nucleic Acid Chemistry

Cited by 635

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

Schatz, J. H., Oricchio, E., Wolfe, A. L., Jiang, M., Linkov, I., Maragulia, J., Shi, W., Zhang, Z., Rajasekhar, V. K., Pagano, N. C., et al. (2011) · Journal of Experimental Medicine

PI3K/AKT/mTOR signaling in cancerLymphoma Diagnosis and Treatment

Cited by 119

KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance

Ash, L. J., Busia-Bourdain, O., Okpattah, D., Kamel, A., Liberchuk, A., & Wolfe, A. L. (2024) · Current Oncology

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 68

NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy

Sanghvi, V. R., Mohan, P., Singh, K., Cao, L., Berishaj, M., Wolfe, A. L., Schatz, J. H., Lailler, N., de Stanchina, E., Viale, A., et al. (2021) · Cancers

Genomics, phytochemicals, and oxidative stressPI3K/AKT/mTOR signaling in cancer

Cited by 27

Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability

Kim, S., Wolfe, A., & Kim, S. E. (2021) · Molecular & Cellular Oncology

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 12

IMPlications of IMP2 in RNA Biology and Disease

Das, J., Busia-Bourdain, O., Khan, K. M., & Wolfe, A. L. (2025) · International Journal of Molecular Sciences

RNA modifications and cancerRNA Research and Splicing

Cited by 3